Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

Condition:   Tuberculosis, Pulmonary Interventions:   Drug: High-dose rifampicin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifampicin Sponsors:   Seoul National University Hospital;   Chonnam National University Hospital;   National Medical Center, Seoul;   Pusan National University Hospital;   Pusan National University Yangsan Hospital;   Seoul National University Bundang Hospital;   SMG-SNU Boramae Medical C enter;   Severance Hospital;   Korean Institute of Tuberculosis;   International Tuberculosis Research Center;   Korean Center for Disease Control and Prevention Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials